- Loss of Smell More Common in COVID-19 Than Thought
- Psoriasis Meds Don’t Raise Risk of Severe COVID-19: Study
- Diet Drinks Don’t Do Your Heart Any Favors
- Lockdowns Can Widen Kids’ Waistlines – Here’s How to Curb That
- Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectivenes
- Health Highlights: Oct. 27, 2020
- Kidney Trouble Greatly Raises Odds for Fatal COVID-19
- MRIs Might Be Safe for Patients With Implanted Heart Devices
- More Evidence Masks Slow COVID’s Spread
- Dangerous COVID-19 Syndrome First Seen in Kids Also Strikes Adults
Clinical Trials Update: July 6, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Flu Symptoms (Ages 55-80)
This study is for people aged 55 to 80 with “flu-like” symptoms. If you qualify, you will receive study-related medication and exams at no cost, and may be compensated for time and travel.
The research site is in Birmingham, Ala.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/flu.aspx.
—–
Alzheimer’s Disease (Ages 50+)
This study is evaluating a once-a day drink on people with mild-to-moderate Alzheimer’s disease.
The research site is in Denver, Colo.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/alzheimers_disease.aspx.
—–
Major Depression
This study of an antidepressant drug is for people aged 18 to 65 who have had major depression for at least four weeks.
The research site is in Prairie Village, Kan.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
